<?xml version="1.0" encoding="UTF-8"?>
<p id="Par38">The chymotrypsin-like protease (3CL
 <sup>pro</sup>) is vital for SARs-CoV replication and is therefore a promising drug target. The active site of SARS-CoV 3CL
 <sup>pro</sup> has a catalytic dyad with the sulfur of Cys145 as a nucleophile and the imidazole ring of His41 as a general base (Ryu et al. 
 <xref ref-type="bibr" rid="CR100">2010a</xref>). Also called main protease (M
 <sup>pro</sup>), the 3CL
 <sup>pro</sup> of SARS-CoV mediates the proteolytic processing of replicase polypeptides 1a and 1ab into functional proteins; thus, it is an important target for drug development (Lin et al. 
 <xref ref-type="bibr" rid="CR70">2005</xref>). Curcumin inhibits SARS-CoV 3CL
 <sup>pro</sup> (IC
 <sub>50</sub> value of 23.5 μM) (Ryu et al. 
 <xref ref-type="bibr" rid="CR100">2010a</xref>). The extracts of 
 <italic>Cibotium barometz</italic> (L.) J.Sm. and 
 <italic>Dioscorea batatas</italic> Decne. also inhibited SARS-CoV 3CL
 <sup>pro</sup> activity with IC
 <sub>50</sub> values of 39 μg/ml and 44 μg/ml, respectively (Cuong et al. 
 <xref ref-type="bibr" rid="CR24">2009</xref>; Wen et al. 
 <xref ref-type="bibr" rid="CR117">2011</xref>). Tannic acid, 3-isotheaflavin-3-gallate, and theaflavin-3,3′-digallate, three phenolic compounds from black tea, inhibit SARS-CoV 3CL
 <sup>pro</sup> with IC
 <sub>50</sub> values of 3, 7, and 9.5 μM, respectively (Chen et al. 
 <xref ref-type="bibr" rid="CR9">2005</xref>).
</p>
